TWI327919B - Precursor of n-acetylgalactosamine-4-sulfatase, methods of treatment using said enzyme and methods for producing and purifying said enzyme - Google Patents

Precursor of n-acetylgalactosamine-4-sulfatase, methods of treatment using said enzyme and methods for producing and purifying said enzyme Download PDF

Info

Publication number
TWI327919B
TWI327919B TW092131341A TW92131341A TWI327919B TW I327919 B TWI327919 B TW I327919B TW 092131341 A TW092131341 A TW 092131341A TW 92131341 A TW92131341 A TW 92131341A TW I327919 B TWI327919 B TW I327919B
Authority
TW
Taiwan
Prior art keywords
precursor
sulfatase
enzyme
purity
acetylgalactosamine
Prior art date
Application number
TW092131341A
Other languages
English (en)
Chinese (zh)
Other versions
TW200427459A (en
Inventor
Qin Minmin
M Henstrand John
N Zecherle Gary
J Wendt Dan
Chan Wai-Pan
Chen Lin
A Fitzpatrick Paul
M Starr Christopher
Swiedler Stuart
Original Assignee
Biomarin Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomarin Pharm Inc filed Critical Biomarin Pharm Inc
Publication of TW200427459A publication Critical patent/TW200427459A/zh
Application granted granted Critical
Publication of TWI327919B publication Critical patent/TWI327919B/zh

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 and B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or chiral chromatography
    • B01D15/3804—Affinity chromatography
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/32—Bonded phase chromatography
    • B01D15/325—Reversed phase
    • B01D15/327—Reversed phase with hydrophobic interaction
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 and B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or chiral chromatography
    • B01D15/3804—Affinity chromatography
    • B01D15/3828—Ligand exchange chromatography, e.g. complexation, chelation or metal interaction chromatography
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/06—Sulfuric ester hydrolases (3.1.6)
    • C12Y301/06012—N-Acetylgalactosamine-4-sulfatase (3.1.6.12)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Otolaryngology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
TW092131341A 2002-11-07 2003-11-07 Precursor of n-acetylgalactosamine-4-sulfatase, methods of treatment using said enzyme and methods for producing and purifying said enzyme TWI327919B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/290,908 US6866844B2 (en) 2002-11-07 2002-11-07 Precursor N-acetylgalactosamine-4-sulfatase, methods of treatment using said enzyme and methods for producing and purifying said enzyme

Publications (2)

Publication Number Publication Date
TW200427459A TW200427459A (en) 2004-12-16
TWI327919B true TWI327919B (en) 2010-08-01

Family

ID=32312121

Family Applications (1)

Application Number Title Priority Date Filing Date
TW092131341A TWI327919B (en) 2002-11-07 2003-11-07 Precursor of n-acetylgalactosamine-4-sulfatase, methods of treatment using said enzyme and methods for producing and purifying said enzyme

Country Status (17)

Country Link
US (1) US6866844B2 (OSRAM)
EP (2) EP1565209B1 (OSRAM)
JP (1) JP4459059B2 (OSRAM)
CN (1) CN100374157C (OSRAM)
AR (1) AR042019A1 (OSRAM)
AU (1) AU2003290642B2 (OSRAM)
BR (1) BRPI0316039B1 (OSRAM)
CA (1) CA2502928C (OSRAM)
CY (1) CY1116164T1 (OSRAM)
DK (1) DK2327414T3 (OSRAM)
ES (2) ES2445028T3 (OSRAM)
IL (1) IL168435A (OSRAM)
MX (1) MXPA05004880A (OSRAM)
PT (2) PT2327414E (OSRAM)
SI (1) SI2327414T1 (OSRAM)
TW (1) TWI327919B (OSRAM)
WO (1) WO2004043373A2 (OSRAM)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6972124B2 (en) * 2000-05-01 2005-12-06 Biomarin Pharmaceuticals Inc. Precursor of N-acetylgalactosamine-4-sulfatase, methods of treatment using said enzyme and methods for producing and purifying said enzyme
ATE511645T1 (de) * 2006-03-17 2011-06-15 Biomarin Pharm Inc Testverfahren zum nachweis von antikörpern gegen lysosomenenzyme
CN101539550B (zh) * 2009-04-28 2012-05-23 李绍平 用于多糖的定性与定量分析方法
ES2896060T3 (es) 2010-06-25 2022-02-23 Shire Human Genetic Therapies Métodos y composiciones para la administración al SNC de arilsulfatasa A
AU2011270670B2 (en) 2010-06-25 2017-01-12 Takeda Pharmaceutical Company Limited Methods and compositions for CNS delivery of arylsulfatase A
SG187834A1 (en) * 2010-08-20 2013-03-28 Boehringer Ingelheim Int Method for inactivating proteases by ph change in a liquid obtained from a cell culture
WO2013094579A1 (ja) 2011-12-20 2013-06-27 日本ケミカルリサーチ株式会社 ホルミルグリシン残基の分析法
WO2013096899A2 (en) 2011-12-23 2013-06-27 Shire Human Genetic Therapies, Inc. Stable formulations for cns delivery of arylsulfatase a
JP6602765B2 (ja) * 2013-09-05 2019-11-06 ジェネンテック， インコーポレイテッド クロマトグラフィー再使用のための方法
FR3011468B1 (fr) * 2013-10-04 2015-12-04 Inventiva Utilisation de l'odiparcil dans le traitement d'une mucopolysaccharidose
US11584777B2 (en) 2017-08-31 2023-02-21 Green Cross Corporation Method for purifying a sulfatase protein
AR119264A1 (es) * 2019-06-05 2021-12-09 Genentech Inc Método para reutilización de cromatografía

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL281225A (OSRAM) 1961-07-20
US3472931A (en) 1969-01-17 1969-10-14 Foster Milburn Co Percutaneous absorption with lower alkyl amides
US3891757A (en) 1971-11-11 1975-06-24 Alza Corp Anaesthetic topical and percutaneous administration with selected promoters
SE387536B (sv) 1973-03-13 1976-09-13 Astra Laekemedel Ab Forfarande for framstellning av en lokalanestetisk beredning
WO2001083722A2 (en) 2000-05-01 2001-11-08 Biomarin Pharmaceuticals Enzymes useful for treating and methods for treating mps-vi and cells lines for producing such enzymes recombinantly

Also Published As

Publication number Publication date
EP1565209B1 (en) 2013-11-06
US20040101524A1 (en) 2004-05-27
PT2327414E (pt) 2015-04-13
WO2004043373A2 (en) 2004-05-27
AU2003290642A1 (en) 2004-06-03
US6866844B2 (en) 2005-03-15
CN100374157C (zh) 2008-03-12
EP1565209A2 (en) 2005-08-24
AU2003290642B2 (en) 2008-07-10
AR042019A1 (es) 2005-06-08
BRPI0316039B8 (OSRAM) 2021-05-25
BRPI0316039B1 (pt) 2017-08-29
EP2327414A1 (en) 2011-06-01
PT1565209E (pt) 2014-02-13
CA2502928A1 (en) 2004-05-27
EP2327414B1 (en) 2015-01-07
IL168435A (en) 2014-07-31
DK2327414T3 (en) 2015-04-13
WO2004043373A3 (en) 2004-08-05
CA2502928C (en) 2013-07-16
CN1726046A (zh) 2006-01-25
EP1565209A4 (en) 2008-01-02
JP4459059B2 (ja) 2010-04-28
MXPA05004880A (es) 2005-07-22
HK1157215A1 (en) 2012-06-29
ES2445028T3 (es) 2014-02-27
BR0316039A (pt) 2005-09-13
ES2533770T3 (es) 2015-04-15
CY1116164T1 (el) 2017-02-08
TW200427459A (en) 2004-12-16
SI2327414T1 (sl) 2015-05-29
JP2006510356A (ja) 2006-03-30

Similar Documents

Publication Publication Date Title
TWI870336B (zh) 重組人類酸性α-葡萄糖苷酶
DE69631544T2 (de) Fettleibigkeitsprotein (ob) zur erhögung der mageren körpermasse
US20080260715A1 (en) Precursor N-acetylgalactosamine-4 sulfatase, methods of treatment using said enzyme and methods for producing and purifying said enzyme
JP2015520128A (ja) 長時間作用性オキシントモジュリン変異体とその作製方法
JP2004502456A5 (OSRAM)
EA011390B1 (ru) Мутантные белки (мутеины) фактора роста фибробластов 21
JP2006312648A (ja) 組換えα−Ｌ−イズロニダーゼ、その生成及び精製方法及びその欠失により引き起こされる疾病の処理方法
RU2751235C2 (ru) Терапевтические слитые белки направленного действия на основе лизосомных ферментов, соответствующие составы и их применения
JP4459059B2 (ja) 前駆体ｎ−アセチルガラクトサミン−４−スルファターゼ、当該酵素を使用した治療方法、ならびに当該酵素の生産および精製方法
JP2022118184A (ja) コンジュゲートされたｃ１エステラーゼインヒビター及びその使用
US20160303150A1 (en) Deuterated trehalose formulations and uses thereof
CN114729344A (zh) 人重组精氨酸酶1的生产方法及其用途
CA2443555C (en) Enzymes useful for treating and methods for treating mps-vi and cells lines for producing such enzymes recombinantly
AU2001255771A1 (en) Enzymes useful for treating and methods for treating MPS-VI and cell lines for producing such enzymes recombinantly
CN114341333A (zh) 用于捕获和纯化生物制品的方法
CN109196097B (zh) 用于选择高m6p重组蛋白的方法
HK1079713A (en) Precursor n-acetylgalactosamine-4-sulfatase, methods of treatment using said enzyme and methods for producing and purifying said enzyme
HK1079713B (en) Precursor n-acetylgalactosamine-4-sulfatase, methods of treatment using said enzyme and methods for producing and purifying said enzyme
HK1157215B (en) Precursor n-acetylgalactosamine-4-sulfatase, methods of treatment using said enzyme and methods for producing and purifying said enzyme
EP1716865A1 (en) Paraoxonase-containing pharmaceutical preparation
HK40072878A (en) Method for capturing and purification of biologics
HK1099219A (en) Long acting erythropoietins that maintain tissue protective activity of endogenous erythropoietin

Legal Events

Date Code Title Description
MK4A Expiration of patent term of an invention patent